This inventor holds 1 USPTO granted patent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2026
Title: Innovations by Florian Reiterer in Insulin Delivery Systems.
Introduction
Florian Reiterer is an accomplished inventor based in Linz, Austria. He has made significant contributions to the field of medical technology, particularly in the area of insulin delivery systems. His innovative approach aims to improve the management of diabetes through advanced methods of insulin administration.
Latest Patents
Reiterer holds a patent for a method of determining a bolus to be administered by an insulin delivering device. This patent outlines a process that utilizes glucose measurement data from continuous glucose sensors to calculate the appropriate insulin dosage. The method incorporates a formula that considers factors such as glucose levels, carbohydrate-to-insulin ratio (CIR), and insulin sensitivity factor (ISF). This technology can be implemented in various devices, including insulin pens, pumps, and portable electronic devices like smartphones and tablets.
Career Highlights
Throughout his career, Florian Reiterer has focused on enhancing diabetes management through innovative solutions. His work has been recognized for its potential to significantly improve the quality of life for individuals with diabetes. The development of his patented method showcases his commitment to advancing medical technology.
Collaborations
Reiterer has collaborated with Luigi Del Re, contributing to the development and refinement of his innovative insulin delivery methods. Their partnership has been instrumental in bringing new ideas to fruition in the medical technology sector.
Conclusion
Florian Reiterer's contributions to insulin delivery systems exemplify the impact of innovation in healthcare. His patented method represents a significant advancement in diabetes management, showcasing the potential for technology to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile